Related Experiment Video
Updated: Jun 30, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton
V E Macrae1, S Horvat, S C Pells
1Bone Biology Group, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin Biocentre, Roslin, UK. vicky.macrae@roslin.ed.ac.uk
Abstract:
Suppressor of cytokine signalling-2 (SOCS2) negatively regulates the signal transduction of several cytokines. Socs2(-/-) mice show increased longitudinal skeletal growth associated with deregulated GH/IGF-1 signalling. The present study examined the role of SOCS2 in endochondral ossification and trabecular and cortical bone formation, and investigated whether pro-inflammatory cytokines associated with pediatric chronic inflammatory disorders mediate their effects through SOCS2. Seven-week-old Socs2(-/-) mice were heavier (27%; P < 0.001) and longer (6%; P < 0.001) than wild-type mice. Socs2(-/-) tibiae were longer (8%; P < 0.001) and broader (18%; P < 0.001) than that of wild-type mice, and the Socs2(-/-) mice had wider growth plates (24%; P < 0.001) with wider proliferative and hypertrophic zones (10% (P < 0.05) and 14% (P < 0.001) respectively). Socs2(-/-) mice showed increased total cross-sectional bone area (16%: P < 0.001), coupled to increased total tissue area (17%; P < 0.05) compared to tibia from wild-type mice. Socs2(-/-) mice showed increased percent bone volume (101%; P < 0.001), trabecular number (82%; P < 0.001) and trabecular thickness (11%; P < 0.001), with associated decreases in trabecular separation (19%; P < 0.001). TNFalpha exposure to growth plate chondrocytes for 48 h increased SOCS2 protein expression. Growth of metatarsals from 1-day-old Socs2(-/-) and Socs2(+/+) mice, as well as expression of Aggrecan, Collagen Type II and Collagen Type X, were inhibited by TNFalpha, with no effect of genotype. Our data indicate that physiological levels of SOCS2 negatively regulate bone formation and endochondral growth. Our results further suggest that pro-inflammatory cytokines mediate their inhibitory effects on longitudinal bone growth through a mechanism that is independent of SOCS2.
Insights
Suppressor of cytokine signalling-2 (SOCS2) negatively regulates bone formation and growth. Pro-inflammatory cytokines inhibit bone growth independently of SOCS2, suggesting new therapeutic targets for bone disorders.
Area of Science:
- Endocrinology
- Bone Biology
- Molecular Regulation
Background:
- Suppressor of cytokine signalling-2 (SOCS2) is a negative regulator of cytokine signal transduction.
- Socs2 knockout mice exhibit enhanced skeletal growth, indicating a role in bone regulation.
Purpose of the Study:
- To investigate the role of SOCS2 in endochondral ossification and bone formation.
- To determine if pro-inflammatory cytokines, relevant to chronic inflammatory disorders, exert effects via SOCS2.
Main Methods:
- Comparative analysis of skeletal growth and bone parameters in Socs2(-/-) and wild-type mice.
- In vitro studies involving TNF-alpha exposure to growth plate chondrocytes and metatarsal explants.
Main Results:
- Socs2(-/-) mice displayed significantly increased body length, tibial length and width, and growth plate dimensions.
- Bone analysis revealed increased cross-sectional area, bone volume, trabecular number, and thickness in Socs2(-/-) mice.
- TNF-alpha increased SOCS2 expression but inhibited metatarsal growth independently of genotype, indicating SOCS2-independent cytokine effects.
Conclusions:
- Physiological levels of SOCS2 negatively regulate bone formation and endochondral growth.
- Pro-inflammatory cytokines inhibit longitudinal bone growth through a SOCS2-independent mechanism.
Related Concept Videos
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
Growth of Cartilage and Bone Tissue
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Formation by Endochondral Ossification

